Repligen Corp reports results for the quarter ended June 30 - Earnings Summary

Repligen

28/07/2026 14:35

Repligen Corp RGEN.OQ reported quarterly adjusted earnings of 54 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 37 cents.  The mean expectation of nineteen analysts for the quarter was for earnings of 45 cents per share. Wall Street expected results to range from 41 cents to 47 cents per share.
Revenue rose 11.9% to $204.13 million from a year ago; analysts expected $201.48 million. 
Repligen Corp's reported EPS for the quarter was 9 cents​.
The company reported quarterly net income of $5.01 million.
Repligen Corp shares had fallen by 3.9% this quarter and lost 20.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 3.6% in the last three months.​ 
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Repligen Corp is $185.00, about 29.2% above its last closing price of $131.06
This summary was machine generated from LSEG data July 28 at 01:35 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.45
0.54
Beat
Mar. 31 2026 
0.39
0.48
Beat
Dec. 31 2025 
0.44
0.49
Beat
Sep. 30 2025 
0.42
0.46
Beat